Gene · 4881
Papers1,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Subclinical Acute Kidney Injury in COVID-19: Possible Mechanisms and Future Perspectives. | Int J Mol Sci | 2022 | 36430671 | PubTator, text mining | PubMed |
Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI? | Biomedicines | 2022 | 36428528 | PubTator, text mining | PubMed |
| In Silico Study of the Mechanisms Underlying the Action of the Snake Natriuretic-Like Peptide Lebetin 2 during Cardiac Ischemia. | Toxins (Basel) | 2022 | 36422961 | PubTator, text mining | PubMed |
| Gain-of-function mutant of movement protein allows systemic transport of a defective tobacco mosaic virus. | iScience | 2022 | 36419850 | PubTator, text mining | PubMed |
| Cooling down with Entresto. Can sacubitril/valsartan combination enhance browning more than coldness? | Diabetol Metab Syndr | 2022 | 36419097 | PubTator, text mining | PubMed |
| Vicinal glutamates are better phosphomimetics: Phosphorylation is required for allosteric activation of guanylyl cyclase-A. | Front Mol Neurosci | 2022 | 36407758 | PubTator, text mining | PubMed |
| Injectable Hydrogel Based on Gellan Gum/Silk Sericin for Application as a Retinal Pigment Epithelium Cell Carrier. | ACS Omega | 2022 | 36406493 | PubTator, text mining | PubMed |
| Effect of the m6ARNA gene on the prognosis of thyroid cancer, immune infiltration, and promising immunotherapy. | Front Immunol | 2022 | 36389678 | PubTator, text mining | PubMed |
| Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2. | Front Med (Lausanne) | 2022 | 36388923 | PubTator, text mining | PubMed |
| Genetic architecture of natural variation of cardiac performance from flies to humans. | Elife | 2022 | 36383075 | PubTator, text mining | PubMed |
| Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs. | Clin Sci (Lond) | 2022 | 36367091 | PubTator, text mining | PubMed |
| pH-Sensitive Targeting of Tumors with Chemotherapy-Laden Nanoparticles: Progress and Challenges. | Pharmaceutics | 2022 | 36365245 | PubTator, text mining | PubMed |
| Natriuretic Peptides-New Targets for Neurocontrol of Blood Pressure via Baroreflex Afferent Pathway. | Int J Mol Sci | 2022 | 36362405 | PubTator, text mining | PubMed |
| Ligand-Dependent Downregulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Role of miR-128 and miR-195. | Int J Mol Sci | 2022 | 36362173 | PubTator, text mining | PubMed |
| An update on the interaction between COVID-19, vaccines, and diabetic kidney disease. | Front Immunol | 2022 | 36341356 | PubTator, text mining | PubMed |
| Soluble Corin Predicts the Risk of Cardiovascular Disease: A 10-Year Follow-Up Study. | JACC Asia | 2022 | 36339355 | PubTator, text mining | PubMed |
| ESR1 dysfunction triggers neuroinflammation as a critical upstream causative factor of the Alzheimer's disease process. | Aging (Albany NY) | 2022 | 36326669 | PubTator, text mining | PubMed |
| In silico study of inhibitory capacity of sacubitril/valsartan toward neprilysin and angiotensin receptor. | RSC Adv | 2022 | 36321085 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges. | Pharmaceutics | 2022 | 36297672 | PubTator, text mining | PubMed |
| Lack of NPR1 Increases Vascular Endothelial Adhesion through Induction of Integrin Beta 4. | Int J Mol Sci | 2022 | 36293483 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4881/papers?page=14